Clinicopathologic features and outcomes of patients with microsatellite instability-high endometrial cancer treated with pembrolizumab in Japan: the KCOG-G1902S/1903S study.

Kashima Y, Murakami K, Otani T, Yoriki K, Kaneda M, Fujiwara S, Katsuda T, Nagano H, Hayasaki Y, Kai K, Arakawa A, Mochizuki A, Hirashima Y, Iwahashi N, Motohashi T, Yoshioka E, Ito K, Nakai H, Matsumura N

Open source

DOI
10.3802/jgo.2027.38.e19
Published
2026 Aug 24
Container
Journal of gynecologic oncology
Publisher
Not recorded
Open access
unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.3802/jgo.2027.38.e19,
  title = {Clinicopathologic features and outcomes of patients with microsatellite instability-high endometrial cancer treated with pembrolizumab in Japan: the KCOG-G1902S/1903S study.},
  author = {Kashima Y and Murakami K and Otani T and Yoriki K and Kaneda M and Fujiwara S and Katsuda T and Nagano H and Hayasaki Y and Kai K and Arakawa A and Mochizuki A and Hirashima Y and Iwahashi N and Motohashi T and Yoshioka E and Ito K and Nakai H and Matsumura N},
  year = {2026},
  journal = {Journal of gynecologic oncology},
  doi = {10.3802/jgo.2027.38.e19},
  url = {https://doi.org/10.3802/jgo.2027.38.e19}
}

RIS

TY  - JOUR
TI  - Clinicopathologic features and outcomes of patients with microsatellite instability-high endometrial cancer treated with pembrolizumab in Japan: the KCOG-G1902S/1903S study.
AU  - Kashima Y
AU  - Murakami K
AU  - Otani T
AU  - Yoriki K
AU  - Kaneda M
AU  - Fujiwara S
AU  - Katsuda T
AU  - Nagano H
AU  - Hayasaki Y
AU  - Kai K
AU  - Arakawa A
AU  - Mochizuki A
AU  - Hirashima Y
AU  - Iwahashi N
AU  - Motohashi T
AU  - Yoshioka E
AU  - Ito K
AU  - Nakai H
AU  - Matsumura N
PY  - 2026
JO  - Journal of gynecologic oncology
DO  - 10.3802/jgo.2027.38.e19
UR  - https://doi.org/10.3802/jgo.2027.38.e19
ER  - 

APA

Y, K., K, M., T, O., K, Y., M, K., S, F., T, K., H, N., Y, H., K, K., A, A., A, M., Y, H., N, I., T, M., E, Y., K, I., H, N., & N, M. (2026). Clinicopathologic features and outcomes of patients with microsatellite instability-high endometrial cancer treated with pembrolizumab in Japan: the KCOG-G1902S/1903S study.. Journal of gynecologic oncology. https://doi.org/10.3802/jgo.2027.38.e19

Source records